Search results
In this population-level, value-based cohort study, there was a significant increase in mean per-person health care costs over time, largely due to the high costs of immunotherapies and targeted systemic therapies for the treatment of advanced and metastatic melanoma.
1 kwi 2024 · In recent years, advances in melanoma treatment have renewed patient hope. This comprehensive review emphasizes the evolving treatment landscape, particularly highlighting first-line strategies and the interplay between immune-checkpoint inhibitors (ICIs) and targeted therapies.
3 sty 2019 · What is a life worth? Does it come down to dollars and cents? A recent study examines these questions in light of current and projected costs of melanoma treatment.
1 sie 2004 · Older individuals are both more likely to acquire and to die from melanoma, and the elderly should therefore be a primary target for secondary melanoma prevention, ie, early detection and screening to reduce melanoma mortality. Treatment options in the elderly may also be limited due to decreased inability to tolerate medication side effects or ...
Among studies examining all stages of melanoma, annual treatment costs ranged from $44.9 million among Medicare patients with existing cases to $932.5 million among newly diagnosed cases across all age groups. Conclusions.
26 kwi 2024 · Given the costs of treatment both in terms of burden on patients (toxicity, time spent in hospital, and impact on quality of life) and on the health care services (in particular, very high drug costs and resource use), there is a huge need to personalize treatment.
Among studies examining all stages of melanoma, annual treatment costs ranged from $44.9 million among Medicare patients with existing cases to $932.5 million among newly diagnosed cases across all age groups.
